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To the Editor:
Anderson and Kippelen reviewed the mechanisms of and therapeutic approaches to
exercise-induced bronchoconstriction (EIB) in athletes.1  In addition to the treatments they
discussed, vitamin C may also affect EIB.
We carried out a systematic review of the effect of vitamin C supplementation on the
common cold.2,3 Vitamin C consistently reduced the duration of common cold symptoms, but
the effect on the common cold incidence was significantly heterogeneous. In the general
population, vitamin C supplementation had no preventive effect; however, the supplements
halved the incidence of colds in six placebo-controlled trials with participants under heavy
acute physical stress: pooled RR = 0.50 (95% CI: 0.38-0.66; total n = 642).  Four of these trials
were with marathon runners, one was with Canadian soldiers in a Northern training exercise,
and one was with schoolchildren in a skiing camp in the Swiss Alps.2,3
In the general community, the acute symptoms of cough, sore throat and running nose
usually have viral etiology. However, it is not obvious that similar symptoms occurring after a
marathon run are caused by a viral infection, as they can result from an injury to runners’
airways caused by their hours of exceptional ventilatory exertion.1  Thus, the common cold
studies of marathon runners may have been measuring, at least in part, the effects of vitamin C
on the physical injury to their airways instead of viral infections.
In their trial with marathon runners, Peters et al. recorded the “self-reported symptoms
including a running nose, sneezing, sore throat, cough, and fever” during a two-week post-race
period.4 The incidence of post-race cough was significantly reduced in the vitamin C group as
compared to the placebo group: RR = 0.29 (95% CI: 0.10-0.83; 4/43 vs. 13/41). The incidence
of sore throat was also reduced by vitamin C: RR = 0.33 (95% CI: 0.16-0.66; 8/43 vs. 23/41).
In contrast, vitamin C had no significant effect on the incidence of runny nose (p = 0.2). Peters
did not carry out virologic or pulmonary function tests before and after the race and thus the
etiology of the symptoms is uncertain, yet there is no strong basis to assume viruses caused the
symptoms. Furthermore, a few studies have directly measured the effect of vitamin C
supplementation on bronchial responsiveness.
Ogilvy et al. reported that vitamin C reduced the duration and intensity of
bronchoconstriction induced by methacholine.5  The action of vitamin C was abolished by
indomethacin, indicating that the effect was mediated via the prostaglandin metabolism.5
Direct evidence indicating that vitamin C affects EIB was found in three small (n ? 20)
laboratory studies in which the fall of FEV1 after exercise was attenuated by vitamin C
supplementation.6-8  Tecklenburg et al. also reported that vitamin C decreased the levels of
proinflammatory eicosanoids in urine.8  These three laboratory studies do not, however, define
the clinical importance of vitamin C for athletes.  On the other hand, the six trials with
participants under heavy acute physical stress2,3 indicate that vitamin C has clinically important
effects on the respiratory symptoms of some athletes, although it is not clear to what degree
that effect is directed at their viral infections and the physical injury to their airways. This
means that more trials that examine the mechanisms and therapeutic effects of vitamin C on the
respiratory symptoms of athletes are warranted.
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